Source link : https://www.newshealth.biz/health-news/two-new-drugs-approved-for-age-related-macular-degeneration/
The European Medicines Agency (EMA) has announced its approval of two new biosimilar medications, Afqlir and Opuviz, to treat age-related macular degeneration (ARMD). The active ingredient of both agents is aflibercept, already used in the similar medication Eylea, authorized in 2012. At a meeting of the Committee for Medicinal Products for Human Use (CHMP), both […]
Author : News Health
Publish date : 2024-09-20 15:29:17
Copyright for syndicated content belongs to the linked Source.
Categories